33.81
price down icon2.54%   -0.88
after-market アフターアワーズ: 33.77 -0.04 -0.12%
loading

Vor Biopharma Inc (VOR) 最新ニュース

pulisher
11:48 AM

Vor Biopharma: Transformed Company Is A High Risk Buy On Autoimmune Disease Promise - Seeking Alpha

11:48 AM
pulisher
10:40 AM

Vor Biopharma Shares Slide Following Warrant Registration Filing - MSN

10:40 AM
pulisher
10:17 AM

Vor Biopharma stock drops after filing to register warrant shares By Investing.com - Investing.com Nigeria

10:17 AM
pulisher
09:26 AM

Vor Biopharma stock drops after filing to register warrant shares - Investing.com

09:26 AM
pulisher
03:26 AM

Stifel upgrades Vor Biopharma stock to Buy on telitacicept prospects By Investing.com - Investing.com South Africa

03:26 AM
pulisher
Sep 24, 2025

Vor Biopharma (VOR) Registers 51M Shares for Resale, Warrants in Focus - GuruFocus

Sep 24, 2025
pulisher
Sep 24, 2025

Vor Biopharma files for offering of up to 51 million common shares by the selling stockholdersSEC filing - MarketScreener

Sep 24, 2025
pulisher
Sep 24, 2025

Vor Biopharma (VOR) files for 51M share offering by selling stockholders - StreetInsider

Sep 24, 2025
pulisher
Sep 24, 2025

Vor Biopharma upgraded to Buy at Stifel on telitacicept prospects - Seeking Alpha

Sep 24, 2025
pulisher
Sep 24, 2025

Stifel upgrades Vor Biopharma stock to Buy on telitacicept prospects - Investing.com India

Sep 24, 2025
pulisher
Sep 24, 2025

Stifel Nicolaus Upgrades Vor Biopharma (NYSE:VOR) to Buy - MarketBeat

Sep 24, 2025
pulisher
Sep 24, 2025

Vor Biopharma climbs after Stifel upgrades rating on autoimmune drug potential - TradingView

Sep 24, 2025
pulisher
Sep 23, 2025

Vor Biopharma (NYSE:VOR) Stock Price Down 8.6% Following Insider Selling - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Vor Biopharma’s Strategic Moves and Telitacicept’s Potential Drive Buy Rating Amid Stock Decline - TipRanks

Sep 23, 2025
pulisher
Sep 23, 2025

Vor Bio appoints Navid Khan as chief medical affairs officer By Investing.com - Investing.com South Africa

Sep 23, 2025
pulisher
Sep 23, 2025

Vor Bio appoints Navid Khan as chief medical affairs officer - Investing.com

Sep 23, 2025
pulisher
Sep 23, 2025

Vor Biopharma (VOR) Sees Significant Increase in Borrow Rate - GuruFocus

Sep 23, 2025
pulisher
Sep 23, 2025

Vor Bio Appoints Navid Z. Khan, Ph.D., as Chief Medical Affairs Officer - GlobeNewswire

Sep 23, 2025
pulisher
Sep 23, 2025

7 Successful Drug Launches: Vor Bio Taps VYVGART Launch Veteran Navid Khan as Medical Affairs Chief - Stock Titan

Sep 23, 2025
pulisher
Sep 23, 2025

Vor Biopharma (NASDAQ:VOR) Shares Down 7.2%What's Next? - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Vor Biopharma (NYSE:VOR) Major Shareholder Reprogrammed Interchange Llc Sells 22,363 Shares - MarketBeat

Sep 23, 2025
pulisher
Sep 22, 2025

Analysts Set Vor Biopharma Inc. (NYSE:VOR) Price Target at $6.07 - MarketBeat

Sep 22, 2025
pulisher
Sep 21, 2025

Street Watch: Is Vor Biopharma Inc stock overvalued or fairly pricedTrade Entry Summary & Proven Capital Preservation Tips - خودرو بانک

Sep 21, 2025
pulisher
Sep 20, 2025

Vor Biopharma (NYSE:VOR) Major Shareholder Reprogrammed Interchange Llc Sells 447,278 Shares - MarketBeat

Sep 20, 2025
pulisher
Sep 20, 2025

Insider Selling: Vor Biopharma (NYSE:VOR) Major Shareholder Sells 20,000 Shares of Stock - MarketBeat

Sep 20, 2025
pulisher
Sep 20, 2025

Momentum Shift: What is the PEG ratio of Vor Biopharma IncQuarterly Trade Report & Entry Point Confirmation Signals - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

Insider Selling: Vor Biopharma (NYSE:VOR) Major Shareholder Sells 14,240 Shares of Stock - MarketBeat

Sep 20, 2025
pulisher
Sep 19, 2025

Risk Report: Is Vor Biopharma Inc. part of any ETF2025 Price Action Summary & Verified Swing Trading Watchlists - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Reprogrammed Interchange Llc Sells 300,000 Shares of Vor Biopharma (NYSE:VOR) Stock - MarketBeat

Sep 19, 2025
pulisher
Sep 19, 2025

Vor Biopharma Inc. recovery potential after sell offInflation Watch & Weekly Stock Performance Updates - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

How to interpret RSI for Vor Biopharma Inc. stockMarket Performance Summary & Verified Technical Signals - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Will Vor Biopharma Inc. rebound enough to break evenPortfolio Profit Report & Fast Moving Stock Watchlists - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Vor Biopharma ten percent owner sells $688k in shares By Investing.com - Investing.com Australia

Sep 19, 2025
pulisher
Sep 19, 2025

Vor Biopharma (VOR) Faces Trading Halt Amid Reverse Stock Split and Share Sale - GuruFocus

Sep 19, 2025
pulisher
Sep 19, 2025

Vor Biopharma trading halted on Thursday, news pending (VOR:NASDAQ) - Seeking Alpha

Sep 19, 2025
pulisher
Sep 19, 2025

Relative strength of Vor Biopharma Inc. in sector analysis2025 Momentum Check & Real-Time Chart Pattern Alerts - newser.com

Sep 19, 2025
pulisher
Sep 18, 2025

Will Vor Biopharma Inc. bounce back from current supportWeekly Investment Report & Weekly Watchlist for Hot Stocks - newser.com

Sep 18, 2025
pulisher
Sep 18, 2025

What momentum shifts mean for Vor Biopharma Inc.Market Activity Report & Reliable Entry Point Trade Alerts - newser.com

Sep 18, 2025
pulisher
Sep 18, 2025

What’s the recovery path for long term holders of Vor Biopharma Inc.July 2025 Pullbacks & Low Risk High Reward Ideas - newser.com

Sep 18, 2025
pulisher
Sep 18, 2025

Vor Biopharma ten percent owner sells $688k in shares - Investing.com

Sep 18, 2025
pulisher
Sep 18, 2025

Using Bollinger Bands to evaluate Vor Biopharma Inc.Portfolio Gains Summary & Community Consensus Picks - newser.com

Sep 18, 2025
pulisher
Sep 18, 2025

Gains Report: Is Vor Biopharma Inc stock overvalued or fairly pricedWeekly Trend Report & AI Driven Price Predictions - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Vor Biopharma Announces 1-for-20 Reverse Stock Split - TipRanks

Sep 18, 2025
pulisher
Sep 18, 2025

Vor Biopharma (NASDAQ:VOR) Rating Increased to Hold at Zacks Research - MarketBeat

Sep 18, 2025
pulisher
Sep 17, 2025

Vor Bio Announces Oral Presentation of 48-Week China Phase - GlobeNewswire

Sep 17, 2025
pulisher
Sep 17, 2025

Vor Biopharma announces 1-for-20 reverse stock split effective Thursday - Investing.com India

Sep 17, 2025
pulisher
Sep 17, 2025

Weekly Recap: How cyclical is Vor Biopharma Inc.’s revenue stream2025 Market Outlook & High Win Rate Trade Tips - khodrobank.com

Sep 17, 2025
pulisher
Sep 17, 2025

CEO Moves: Can Vor Biopharma Inc keep up with sector leadersJuly 2025 Highlights & Daily Market Momentum Tracking - خودرو بانک

Sep 17, 2025
$34.90
price down icon 2.43%
$81.66
price down icon 2.97%
$28.84
price down icon 2.07%
$98.08
price down icon 1.67%
$135.59
price down icon 3.84%
biotechnology ONC
$328.71
price down icon 0.34%
大文字化:     |  ボリューム (24 時間):